Oxymorphone Extended-Release Tablets and Rescula
Determining the interaction of Oxymorphone Extended-Release Tablets and Rescula and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: oxymorphone
Brand name: Opana, Opana ER, Numorphan HCl
Synonyms: Oxymorphone
Generic Name: unoprostone ophthalmic
Brand name: Rescula
Synonyms: Rescula Ophthalmic Solution
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Oxymorphone Extended-Release Tablets-Rescula Ophthalmic Solution
- Oxymorphone Extended-Release Tablets-Resectisol
- Oxymorphone Extended-Release Tablets-Reserpine
- Oxymorphone Extended-Release Tablets-Reserpine, hydralazine, and hydrochlorothiazide
- Oxymorphone Extended-Release Tablets-Resinol topical
- Oxymorphone Extended-Release Tablets-Resorcinol and sulfur Topical
- Rescula-Oxymorphone Hydrochloride
- Rescula-Oxymorphone Injection
- Rescula-Oxymorphone Tablets
- Rescula-Oxytocin
- Rescula-Oxytocin Intravenous, Intramuscular
- Rescula-Oxytrol